<110>    CHONG KUN DANG PHARMACEUTICAL CORP.

<120>    Compositions for preventing or treating chronic obstructive
         pulmonary diseases(COPD)

<130>    P20018-CKD

<150>    KR 10-2019-0132501
<151>    2019-10-23

<160>    8

<170>    KoPatentIn 3.0

<210>    1
<211>    21
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Primer(F)_mIL-6


<400>    1
ctgcaagaga cttccatcca g                                                   21


<210>    2
<211>    23
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Primer(R)_mIL-6


<400>    2
agtggtatag acaggtctgt tgg                                                 23


<210>    3
<211>    21
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Primer(F)_mIFN-gamma


<400>    3
atgaacgcta cacactgcat c                                                   21


<210>    4
<211>    21
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Primer(R)_mIFN-gamma


<400>    4
ccatcctttt gccagttcct c                                                   21


<210>    5
<211>    23
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Primer(F)_mMCP-1


<400>    5
ttaaaaacct ggatcggaac caa                                                 23


<210>    6
<211>    23
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Primer(R)_mMCP-1


<400>    6
gcattagctt cagatttacg ggt                                                 23


<210>    7
<211>    20
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Primer(F)_mTNF-alpha


<400>    7
ctgaacttcg gggtgatcgg                                                     20


<210>    8
<211>    23
<212>    DNA
<213>    Artificial Sequence

<220>
<223>    Primer(R)_mTNF-alpha


<400>    8
ggcttgtcac tcgaattttg aga                                                 23
